Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2003-11-18
Original market date: See footnote 1
1997-04-14
Product name:
NAROPIN INJ 7.5MG/ML
DIN:
02229416 Electronic product monograph is not available
Company:
ASTRAZENECA CANADA INC
1004 Middlegate Road, Suite 5000
Mississauga
Ontario
Canada
L4Y 1M4
Class:
Human
Dosage form(s):
Liquid
Route(s) of administration:
Parenteral (Unspecified)
Number of active ingredient(s):
1
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
72:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
N01BB09 ROPIVACAINE
Active ingredient group (AIG) number:See footnote5
0133273004
Active ingredient(s) | Strength |
---|---|
ROPIVACAINE HYDROCHLORIDE | 7.5 MG / ML |